Suchergebnisse - "Massanella, Marta"

PubPharm (7)

1

Impact of chemotherapy and/or immunotherapy on neutralizing antibody response to SARS-CoV-2 mRNA-1237 vaccine in patients with solid tumors

enthalten in: Molecular oncology | 2023

von Felip, E. | Pradenas, E. | Romeo, M. | +11

2

Limited Humoral and Specific T-Cell Responses After SARS-CoV-2 Vaccination in PWH With Poor Immune Reconstitution

enthalten in: The Journal of infectious diseases | 2022

von Benet, S. | Blanch-Lombarte, O. | Ainsua-Enrich, E. | +27

3

Glucocorticoids' treatment impairs the medium-term immunogenic response to SARS-CoV-2 mRNA vaccines in Systemic Lupus Erythematosus patients

enthalten in: Scientific reports | 2022

von Garcia-Cirera, S. | Calvet, J. | Berenguer-Llergo, A. | +15

4

Efficacy of SARS-CoV-2 vaccination in patients with monoclonal gammopathies : A cross sectional study

enthalten in: Life science alliance | 2022

von Abella, E. | Trigueros, M. | Pradenas, E. | +21

5

Reduced humoral response 3 months following BNT162b2 vaccination in SARS-CoV-2 uninfected residents of long-term care facilities

enthalten in: Age and ageing | 2022

von Trigueros, M. | Pradenas, E. | Palacín, D. | +67

6

Clinical course impacts early kinetics,magnitude, and amplitude of SARS-CoV-2 neutralizing antibodies beyond 1 year after infection

enthalten in: Cell reports. Medicine | 2022

von Pradenas, E. | Trinité, B. | Urrea, V. | +19

7

Previous SARS-CoV-2 Infection Increases B.1.1.7 Cross-Neutralization by Vaccinated Individuals

enthalten in: Viruses | 2021

von Trinité, B. | Pradenas, E. | Marfil, S. | +24

1
[1]